Fibrin sealants in orthopaedic surgery: practical experiences derived from use of QUIXIL® in total knee arthroplasty
Total knee arthroplasty is associated with a significant postoperative blood loss even without any form of perioperative anticoagulation.
The potential role of QUIXIL®, a fibrin sealant used in orthopaedic surgery to control blood loss and avoid blood transfusions in patients undergoing total knee arthroplasty was evaluated in a prospective randomized trial with twenty-four patients diagnosed with primary osteoarthritis of the knee.
Results showed that application of 2 ml QUIXIL® adds costs to treatment without reducing the number of transfused red blood cell counts and postoperative haemoglobin loss. However, significant lower levels of postoperative fluid loss (P = 0.026) was detected in QUIXIL® treated patients.
Regarding cost effectiveness and benefit no indication for the use of 2 ml QUIXIL® fibrin sealant in standard knee arthroplasty could be proofed statistically.
KeywordsKnee arthroplasty Fibrin sealants Blood loss
Conflict of interest
The authors declare that there has been no conflict of interest.
- 1.Lotke PA, Faralli VJ, Orenstein EM, Ecker ML (1991) Blood loss after total knee replacement: effect of tourniquet release and continuous passive motion. J Bone Joint Surg [Am] 73-A:1037–1040Google Scholar
- 2.Sehat KR, Evans RL, Newman JH (2004) Hidden blood loss following hip and knee arthroplasty. J Bone Joint Surg [Br] 86-B:561–565Google Scholar
- 7.Li B, Liu D, Tian L (2011) The effect of knee position on blood loss and range of motion following total knee arthroplasty. Knee Sports Traumatol Arthrosc (Epub ahead)Google Scholar
- 9.Aksoy Y, Altinel L, Köse KC (2011) The comparison of the effects of intraoperative bleeding control and postoperative drain clamping methods on the postoperative blood loss and the need for transfusion following total knee arthroplasty. Acta Orthop Traumatol Turc 45(3):190–194PubMedCrossRefGoogle Scholar
- 10.Charoencholvanich K, Siriwattansakul P (2011) Tranexamic acid reduced blood loss and blood transfusion after TKA: a prospective randomized controlled trial. Clin Orthop Relat Res (Epub ahead)Google Scholar
- 12.Levy O, Martinovitz U, Oran A, Tauber C, Horoszowski H (1999) The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. a prospective, randomized, multicenter study. J Bone Joint Surg [Am] 81:1580–1588Google Scholar
- 13.Everts PAM, Devilee RJJ, Oosterbos CJM, Mahoney CB, Schattenkerk ME, Knape JTA, Van Zundert A (2007) Autologous platelet gel and fibrin sealant enhance the efficacy of total knee arthroplasty: improved range of motion, decreased length of stay and a reduced incidence of arthrofibrosis. Knee Surg Sports Traumatol Arthrosc 15:888–894PubMedCrossRefGoogle Scholar
- 14.Mawatari M, Higo T, Tsutsumi Y, Shigematsu M, Hotokebuchi T (2006) Effectiveness of autologous fibrin tissue adhesive in reducing postoperative blood loss during total hip arthroplasty: a prospective randomised study of 100 cases. J Orthop Surgery 14(2):117–121Google Scholar
- 15.Steinhubl SR, Bhatt DL, Brennan DM, Montalescot G, Hankey GJ, Eikelboom JW, Berger PB, Topol EJ (2009) Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding. Ann Inter Med 150:379–386Google Scholar
- 16.Gogarten W, Van Aken H (2009) Die neue S3-Leitlinie zur Thromboembolieprophylaxe-Bedeutung für unser Fachgebiet. Anästh Intensivmed 50:316–323Google Scholar
- 17.Carless PA, Henry DA, Anthony DM (2003) Fibrin sealant use for minimising per-operative allogenic blood transfusion. Cochrane Database Syst Rev Issue 1. Art. No.: CD004171. doi: 10.1002/14651858.CD004171
- 18.Summary of product characteristics. Available from: http://www.omrix.com/prescribing/uk.asp
- 19.McManus KT, Velchik MG, Alavi A, Lotke PA (1987) Non-invasive assessment of postoperative bleeding in TKA patients with Tc-99m RBCs. J Nuclear Med 28:565Google Scholar